Corporate Governance Corporate Governance Overview Delivery How our governance supports the delivery of our strategy All Directors are collectively responsible for the success of the Group.
The Non-Executive Directors exercise independent, objective judgement in respect of Board decisions, and scrutinise and challenge management.
They also have various responsibilities concerning the integrity of financial information, internal controls and risk management.
The Board is responsible for setting our strategy and represents the interests of all stakeholders.
and policies, overseeing risk and corporate The Board conducts an annual review of the Groups governance, and monitoring progress towards overall strategy.
The CEO, CFO and Senior Executive meeting our objectives and annual plans.
It is Team SET take the lead in developing our strategy, accountable to our shareholders for the proper which is then reviewed, constructively challenged conduct of the business and our long-term success, and approved by the Board.
Governance structure The Board has delegated some of its powers to the CEO and operates with the assistance of four Committees: Board Corporate Governance Report from page 92 Audit Remuneration Nomination & Science Committee Committee Governance Committee Committee Report from page 100 Report from page 105 page 96 page 97 In addition to the SET, we have two senior level governance bodies: Senior Executive Team SET Details of our SET on page 90 Early Stage Product Committees Late Stage Product Committee page 90 page 90 Attendance in 2017 Board Committee membership and meeting attendance in 2017 Nomination & Board or Committee Chairman Name Board Audit Remuneration Governance Science Genevive Berger 5 6 3 3 Philip Broadley elected 27 April 2017 4 4 3 3 Bruce Burlington retired 31 August 2017 3 3 3 3 3 3 2 2 Ann Cairns retired 27 April 2017 2 2 2 2 Graham Chipchase 5 6 5 5 4 5 Deborah DiSanzo appointed 1 December 2017 1 1 Marc Dunoyer 6 6 Leif Johansson 6 6 4 5 5 5 Rudy Markham 6 6 5 5 5 5 5 5 Sheri McCoy appointed 1 October 2017 2 2 2 2 Nazneen Rahman appointed 1 June 2017 4 4 1 1 Pascal Soriot 6 6 Shriti Vadera 6 6 5 5 5 5 Marcus Wallenberg 4 6 3 3 Note: number in brackets denotes number of meetings during the year that Board members were entitled to attend.
AstraZeneca Annual Report & Form 20-F Information 2017 Corporate Governance Overview 87
